T
TOBAM Portfolio holdings
AUM
$256M
This Quarter Return
+1.57%
1 Year Return
+13.59%
3 Year Return
+36.98%
5 Year Return
+80%
10 Year Return
+220.89%
AUM
$638M
AUM Growth
+$638M
(-43%)
Cap. Flow
-$494M
Cap. Flow
% of AUM
-77.48%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
396
New
19
Increased
56
Reduced
246
Closed
70
Top Buys
| 1 |
Dick's Sporting Goods
DKS
|
$5.73M |
| 2 |
Jabil
JBL
|
$5.57M |
| 3 |
Globe Life
GL
|
$4.7M |
| 4 |
NVIDIA
NVDA
|
$4.56M |
| 5 |
Akamai
AKAM
|
$3.99M |
Top Sells
| 1 |
Progressive
PGR
|
$21.8M |
| 2 |
Eli Lilly
LLY
|
$19.4M |
| 3 |
Newmont
NEM
|
$17.3M |
| 4 |
United Therapeutics
UTHR
|
$16.7M |
| 5 |
McKesson
MCK
|
$16.6M |
Sector Composition
| 1 | Healthcare | 30.76% |
| 2 | Consumer Staples | 20.45% |
| 3 | Technology | 14.41% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $20.1M | 3.15% |
22,172
-21,432
| -49% | -$19.4M |
|
2
AT&T
T
$209B
| $19.1M | 2.99% |
999,054
-654,269
| -40% | -$12.5M |
|
|
3
United Therapeutics
UTHR
$13.8B
| $17.9M | 2.81% |
56,258
-52,389
| -48% | -$16.7M |
|
4
Humana
HUM
$36.5B
| $16.9M | 2.65% |
45,165
-39,777
| -47% | -$14.9M |
|
|
5
McKesson
MCK
$85.4B
| $16.7M | 2.62% |
28,654
-28,409
| -50% | -$16.6M |
|
6
Church & Dwight Co
CHD
$22.7B
| $16.5M | 2.59% |
159,219
-137,198
| -46% | -$14.2M |
|
7
General Mills
GIS
$26.4B
| $16.5M | 2.58% |
260,431
-210,294
| -45% | -$13.3M |
|
8
Cboe Global Markets
CBOE
$24.7B
| $16.3M | 2.55% |
95,805
-65,317
| -41% | -$11.1M |
|
9
AbbVie
ABBV
$372B
| $15.9M | 2.49% |
92,627
-82,734
| -47% | -$14.2M |
|
10
Clorox
CLX
$14.5B
| $14.9M | 2.33% |
109,087
-85,453
| -44% | -$11.7M |
|
11
Pfizer
PFE
$141B
| $14.3M | 2.24% |
511,355
-396,687
| -44% | -$11.1M |
|
12
Merck
MRK
$210B
| $13.6M | 2.13% |
109,482
-98,864
| -47% | -$12.2M |
|
13
Kellanova
K
$27.6B
| $13.1M | 2.05% |
226,763
-210,719
| -48% | -$12.2M |
|
14
Verizon
VZ
$186B
| $13M | 2.03% |
314,527
-231,346
| -42% | -$9.54M |
|
|
15
Newmont
NEM
$81.7B
| $13M | 2.03% |
309,707
-412,087
| -57% | -$17.3M |
|
16
J.M. Smucker
SJM
$11.8B
| $12.5M | 1.95% |
114,244
-109,756
| -49% | -$12M |
|
17
Neurocrine Biosciences
NBIX
$13.8B
| $12.5M | 1.95% |
90,465
-87,788
| -49% | -$12.1M |
|
18
Arista Networks
ANET
$172B
| $12.3M | 1.92% |
34,963
-36,701
| -51% | -$12.9M |
|
19
Kroger
KR
$44.9B
| $11.6M | 1.82% |
232,877
-247,688
| -52% | -$12.4M |
|
20
Johnson & Johnson
JNJ
$427B
| $11.5M | 1.8% |
78,454
-73,639
| -48% | -$10.8M |
|
21
Campbell Soup
CPB
$9.52B
| $11.4M | 1.78% |
251,621
-202,681
| -45% | -$9.16M |
|
22
Hormel Foods
HRL
$14B
| $9.89M | 1.55% |
324,513
-72,341
| -18% | -$2.21M |
|
23
Bristol-Myers Squibb
BMY
$96B
| $9.07M | 1.42% |
218,309
-143,411
| -40% | -$5.96M |
|
|
24
Progressive
PGR
$145B
| $8.38M | 1.31% |
40,359
-104,889
| -72% | -$21.8M |
|
25
MarketAxess Holdings
MKTX
$6.87B
| $8.31M | 1.3% |
41,438
-28,433
| -41% | -$5.7M |
|